Clinical trial
The Treatment Advocacy Program
NCT00164333 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00164333 |
|---|---|
| Title | The Treatment Advocacy Program |
| Official title | The Treatment Advocacy Program |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV |
| Intervention type | Behavioral |
| Interventions | TAP: Treatment Advocacy Program |
| Enrollment | 300 |
| Start date | Sep 1, 2004 |
| Primary completion | May 1, 2007 |
| Completion | Apr 1, 2008 |
| First posted | Sep 14, 2005 |
| Last update posted | Sep 27, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: